144 related articles for article (PubMed ID: 7170020)
1. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
Graham DG; Anthony DC; Boekelheide K
Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
[TBL] [Abstract][Full Text] [Related]
2. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic studies of hexane and carbon disulfide neurotoxicity.
Graham DG; Amarnath V; Valentine WM; Pyle SJ; Anthony DC
Crit Rev Toxicol; 1995; 25(2):91-112. PubMed ID: 7612176
[TBL] [Abstract][Full Text] [Related]
4. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings.
Anthony DC; Boekelheide K; Graham DG
Toxicol Appl Pharmacol; 1983 Dec; 71(3):362-71. PubMed ID: 6686353
[TBL] [Abstract][Full Text] [Related]
5. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.
Graham DG; Szakál-Quin G; Priest JW; Anthony DC
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4979-82. PubMed ID: 6589640
[TBL] [Abstract][Full Text] [Related]
6. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
LoPachin RM; Lehning EJ
Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
[TBL] [Abstract][Full Text] [Related]
7. Studies of the molecular pathogenesis of hexane neuropathy. I. evaluation of the inhibition of glyceraldehyde-3-phosphate dehydrogenase by 2,5-hexanedione.
Graham DG; Abou-Donia MB
J Toxicol Environ Health; 1980 May; 6(3):621-31. PubMed ID: 7420469
[TBL] [Abstract][Full Text] [Related]
8. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat.
Anthony DC; Giangaspero F; Graham DG
J Neuropathol Exp Neurol; 1983 Sep; 42(5):548-60. PubMed ID: 6310058
[TBL] [Abstract][Full Text] [Related]
9. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking.
Anthony DC; Boekelheide K; Anderson CW; Graham DG
Toxicol Appl Pharmacol; 1983 Dec; 71(3):372-82. PubMed ID: 6658787
[TBL] [Abstract][Full Text] [Related]
10. 1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy.
Kim MS; Sabri MI; Miller VH; Kayton RJ; Dixon DA; Spencer PS
Toxicol Appl Pharmacol; 2001 Dec; 177(2):121-31. PubMed ID: 11740911
[TBL] [Abstract][Full Text] [Related]
11. Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione.
DeCaprio AP; Olajos EJ; Weber P
Toxicol Appl Pharmacol; 1982 Sep; 65(3):440-50. PubMed ID: 7157375
[No Abstract] [Full Text] [Related]
12. CS2-mediated cross-linking of erythrocyte spectrin and neurofilament protein: dose response and temporal relationship to the formation of axonal swellings.
Valentine WM; Amarnath V; Graham DG; Morgan DL; Sills RC
Toxicol Appl Pharmacol; 1997 Jan; 142(1):95-105. PubMed ID: 9007038
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of gamma-diketone neurotoxicity: non-neurotoxicity of 3,3-dimethyl-2,5-hexanedione, a gamma-diketone incapable of pyrrole formation.
Sayre LM; Shearson CM; Wongmongkolrit T; Medori R; Gambetti P
Toxicol Appl Pharmacol; 1986 Jun; 84(1):36-44. PubMed ID: 3715867
[TBL] [Abstract][Full Text] [Related]
14. Aromatic as well as aliphatic hydrocarbon solvent axonopathy.
Spencer PS; Kim MS; Sabri MI
Int J Hyg Environ Health; 2002 Mar; 205(1-2):131-6. PubMed ID: 12018006
[TBL] [Abstract][Full Text] [Related]
15. Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
DeCaprio AP; Kinney EA; LoPachin RM
J Toxicol Environ Health A; 2009; 72(14):861-9. PubMed ID: 19557614
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture.
Veronesi B; Peterson ER; Bornstein MB; Spencer PS
J Neuropathol Exp Neurol; 1983 Mar; 42(2):153-65. PubMed ID: 6827287
[TBL] [Abstract][Full Text] [Related]
17. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking.
Graham DG; Anthony DC; Boekelheide K; Maschmann NA; Richards RG; Wolfram JW; Shaw BR
Toxicol Appl Pharmacol; 1982 Jul; 64(3):415-22. PubMed ID: 6814014
[No Abstract] [Full Text] [Related]
18. Hyperbaric oxygen accelerates the neurotoxicity of 2,5-hexanedione.
Rosenberg CK; Anthony DC; Szakál-Quin G; Genter MB; Graham DG
Toxicol Appl Pharmacol; 1987 Feb; 87(2):374-9. PubMed ID: 3824391
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
Griffin JW; Fahnestock KE; Price DL; Cork LC
Ann Neurol; 1983 Jul; 14(1):55-61. PubMed ID: 6684411
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of hexacarbon-neurotoxicity by methyl-ethyl-ketone (MEK) and other substances: clinical and experimental aspects.
Altenkirch H; Wagner HM; Stoltenburg-Didinger G; Steppat R
Neurobehav Toxicol Teratol; 1982; 4(6):623-7. PubMed ID: 7170019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
